Skip to main content
    A

    Amphastar P (AMPH)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $29.17
    -0.20 (-0.68%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Amphastar P (AMPH) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Amphastar P (AMPH) has a market cap of $1.25B and an enterprise value of $1.66B. Its share count is down 8.38% from a year earlier. Its trailing P/E of 10.3x is below its 10-year median of 23.7x.

    Total Valuation

    Enterprise value is 32.61% above the market cap, as debt exceeds cash.

    Market Cap$1.25B
    Enterprise Value$1.66B
    Latest price (Nov 17, 2026)$29.17

    Key Dates

    The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 24, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count fell 2.44% in the quarter ended Sep 30, 2026 and shrank 6.42% a year over 2 years.

    Shares Outstanding42.58M
    Shares Change (YoY)-8.38%
    Shares Change (QoQ)-2.44%
    Share Count Growth (2Y CAGR)-6.42%

    Valuation Ratios

    Sales and book value multiples are 1.7x and 1.5x. Its year-end P/E ranged from 8.8x to 86.5x from 2016 to 2025.

    P/E Ratio10.3x
    Forward P/E9.0x
    P/S Ratio1.7x
    Forward P/S1.7x
    P/B Ratio1.5x
    P/TBV Ratio7.1x
    P/FCF Ratio8.9x
    P/OCF Ratio7.1x

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 7.6x EBITDA and 11.9x free cash flow.

    EV / Earnings16.8x
    EV / Sales2.2x
    EV / EBITDA7.6x
    EV / EBIT11.3x
    EV / FCF11.9x

    Price Statistics

    The stock is up 10.62% over 52 weeks and trades 11.89% above its 50-day average.

    Beta (1Y)0.41
    52-Week Change+10.62%
    1-Month Change+12.76%
    3-Month Change+36.69%
    6-Month Change+69.59%
    5-Year Change+48.39%
    10-Year Change+52.81%
    Total Return (1Y)+10.62%
    Total Return (3Y CAGR)-19.48%
    Total Return (5Y CAGR)+7.74%
    Return vs SPY (1Y)+1.07%
    Max Drawdown (1Y)-42.62%
    Max Drawdown (3Y)-73.41%
    Sharpe Ratio (1Y)0.23
    Correlation with SPY (1Y)0.11
    50-Day Average$26.07
    200-Day Average$22.37
    52-Week Range$16.64 to $31.00
    RSI (14 Days)65.1
    Average Volume (20 Days)478.71K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.32x current liabilities, and total debt is 0.75x shareholder equity.

    Current Ratio3.32x
    Quick Ratio2.36x
    Debt / Equity0.75x
    Debt / EBITDA2.83x
    Debt / FCF4.41x
    Interest Coverage5.52x

    Returns and Efficiency

    Return on invested capital is 7.85% over the last 12 months, against a 5-year average of 12.31%.

    Return on Equity (ROE)12.15%
    Return on Assets (ROA)5.78%
    Return on Invested Capital (ROIC)7.85%
    Return on Capital Employed (ROCE)9.59%
    ROE (5Y Average)17.44%
    ROA (5Y Average)9.39%
    ROIC (5Y Average)12.31%
    Asset Turnover0.44x
    Inventory Turnover2.24x
    Receivables Turnover4.56x
    Cash Conversion Cycle50 days

    Taxes

    Income tax took 23.63% of pretax income over the last 12 months.

    Income Tax (TTM)$30.61M
    Effective Tax Rate23.63%

    Scores

    AMPH has an Altman Z-Score of 2.45, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.

    Altman Z-Score2.45
    Altman Z ZoneGrey
    Piotroski F-Score6 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $745.79M over the last 12 months is up 3.11% from the 12 months before.

    Revenue$745.79M
    Revenue Growth (YoY)+3.11%
    Gross Profit$349.09M
    Operating Income$139.74M
    Pretax Income$129.57M
    Net Income$98.96M
    EBITDA$216.94M
    EBIT$146.78M
    Reported EPS (TTM)$2.84

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 47.63% of the $1.71B in total assets.

    Cash and Equivalents$204.59M
    Total Debt$613.00M
    Net Debt$408.41M
    Net Debt Per Share$9.59
    Working Capital$421.25M
    Shareholder Equity$814.55M
    Book Value Per Share$19.13
    Tangible Book Value$174.13M
    Tangible Book Per Share$4.09
    Total Assets$1.71B
    Total Liabilities$897.17M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $36.31M of capital spending, operating cash flow left $139.01M of free cash flow.

    Operating Cash Flow$175.33M
    Capital Expenditures$36.31M
    Free Cash Flow$139.01M
    FCF Per Share$3.27
    Depreciation and Amortization$70.16M
    Share Repurchases$95.66M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 18.74%, against a 5-year average of 23.13%.

    Gross Margin46.81%
    Operating Margin18.74%
    Pretax Margin17.37%
    Net Margin13.27%
    EBITDA Margin29.09%
    EBIT Margin19.68%
    FCF Margin18.64%
    Gross Margin (5Y Average)50.10%
    Operating Margin (5Y Average)23.13%
    Net Margin (5Y Average)17.91%

    Growth

    Revenue grew 12.99% a year over 3 years, and EPS 15.43% a year.

    Revenue Growth (3Y CAGR)+12.99%
    Revenue Growth (5Y CAGR)+15.53%
    EPS Growth (3Y CAGR)+15.43%
    EPS Growth (5Y CAGR)+36.47%
    FCF Growth (3Y CAGR)+23.00%
    FCF Growth (5Y CAGR)+38.94%
    Operating Income Growth (3Y CAGR)+9.31%
    Book Value Per Share Growth (2Y CAGR)+17.76%
    Tangible Book Per Share Growth (2Y CAGR)+209.64%

    Revenue and profit by year

    Dividends and Yields

    AMPH does not pay a dividend. Its free cash flow yield is 11.19%.

    Earnings Yield9.71%
    FCF Yield11.19%
    Buyback Yield7.37%
    Shareholder Yield7.37%

    Peer Position

    Against 11 similar companies, AMPH has the 9th highest P/E.

    P/E Ratio10.3x vs 12.8x median
    P/S Ratio1.7x vs 2.0x median
    ROIC7.85% vs 11.64% median
    Revenue Growth (Trailing 4 Quarters, YoY)+3.11% vs +19.68% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 4.92% and EPS growth at -5.78% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+4.92%
    EPS Growth Forecast (2Y CAGR)-5.78%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About AMPH

    What is AMPH's market cap?

    Amphastar P has a market cap of $1.25B. Its enterprise value, which adds debt and subtracts cash, is $1.66B.

    What is AMPH's P/E ratio?

    Amphastar P has a trailing P/E ratio of 10.3x and a forward P/E of 9.0x.

    How many shares of AMPH are outstanding?

    Amphastar P has 42.58M shares outstanding. The count is down 8.38% from a year earlier.

    Does AMPH pay a dividend?

    No. Amphastar P does not pay a dividend.

    How much debt does AMPH have?

    Amphastar P has $613.00M of total debt and $204.59M of cash and equivalents, a net debt position of $408.41M.